Affilogic is a private biotech company specialized in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector.

These affinity proteins can be designed as targeted inhibitors, or as vectors for specific addressing of cells and tissues. Affilogic follows the science to any therapeutic area as long as an innovative Nanofitin-based biotherapy can make a difference to meet patients’ needs. Usual systemic routes can be travelled by Nanofitins®, but their intrinsic properties make them amenable to other routes, such as oral route and pulmonary delivery.

To learn more about the use of Nanofitins® as affinity ligands for the purification of biologics, you can visit the dedicated Affichrom’ website.

Affilogic wants to hear from you!

PEGS EUROPE 2022

PEGS EUROPE 2022

Meet our CSO Mathieu Cinier presenting at PEGS EUROPE 2022 in Barcelona – Spain
Nov 14-16, 2022

Visit the event website

BIO Europe Convention 2022

BIO Europe Convention 2022

Meet us at BIO Europe Convention in Leipzig – Germany
Oct 24-26, 2022

Visit the event website

Technology

Your Nanofitins®

Our platforms